Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ionut Bebu

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
American Journal of Epidemiology|August 2, 2022
Cost-Efficient Multiply Matched Case-Control Study DesignsGrecio J Sandoval, Ionut Bebu, John M Lachin
The New England Journal of Medicine|July 13, 2017
Frequency of Evidence-Based Screening for Diabetic RetinopathyDavid M Nathan, Ionut Bebu, John M Lachin
Statistics in Medicine|April 14, 2021
Cost-efficient clinical studies with continuous time survival outcomesGrecio J Sandoval, Ionut Bebu, John M Lachin
Diabetes Care|August 12, 2021
The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 DiabetesJohn M Lachin, Ionut Bebu, David M Nathan, et al.
International Journal of Environmental Research and Public Health|June 21, 2016
Generalized Confidence Intervals and Fiducial Intervals for Some Epidemiological MeasuresIonut Bebu, George Luta, Thomas Mathew, et al.
BMC Research Notes|December 18, 2014
Mediation analysis of gestational age, congenital heart defects, and infant birth-weightAdane F Wogu, Christopher A Loffredo, Ionut Bebu, et al.
Diabetes|June 21, 2020
Comment on Miller and Orchard: Understanding Metabolic Memory: A Tale of Two Studies. Diabetes 2020;69:291-299John M Lachin, David M Nathan, Bernard Zinman, et al.
Plos One|July 13, 2019
Closed testing using surrogate hypotheses with restricted alternativesJohn M Lachin, Ionut Bebu, Michael D Larsen, et al.
Diabetes Care|December 22, 2022
Response to Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448John M Lachin, Ionut Bebu, Xiaoyu Gao, et al.
Diabetes Care|August 16, 2022
Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications TrialJohn M Lachin, Ionut Bebu, Xiaoyu Gao, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
American Journal of Epidemiology|August 2, 2022
Cost-Efficient Multiply Matched Case-Control Study DesignsGrecio J Sandoval, Ionut Bebu, John M Lachin
The New England Journal of Medicine|July 13, 2017
Frequency of Evidence-Based Screening for Diabetic RetinopathyDavid M Nathan, Ionut Bebu, John M Lachin
Statistics in Medicine|April 14, 2021
Cost-efficient clinical studies with continuous time survival outcomesGrecio J Sandoval, Ionut Bebu, John M Lachin
Diabetes Care|August 12, 2021
The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 DiabetesJohn M Lachin, Ionut Bebu, David M Nathan, et al.
International Journal of Environmental Research and Public Health|June 21, 2016
Generalized Confidence Intervals and Fiducial Intervals for Some Epidemiological MeasuresIonut Bebu, George Luta, Thomas Mathew, et al.
BMC Research Notes|December 18, 2014
Mediation analysis of gestational age, congenital heart defects, and infant birth-weightAdane F Wogu, Christopher A Loffredo, Ionut Bebu, et al.
Diabetes|June 21, 2020
Comment on Miller and Orchard: Understanding Metabolic Memory: A Tale of Two Studies. Diabetes 2020;69:291-299John M Lachin, David M Nathan, Bernard Zinman, et al.
Plos One|July 13, 2019
Closed testing using surrogate hypotheses with restricted alternativesJohn M Lachin, Ionut Bebu, Michael D Larsen, et al.
Diabetes Care|December 22, 2022
Response to Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448John M Lachin, Ionut Bebu, Xiaoyu Gao, et al.
Diabetes Care|August 16, 2022
Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications TrialJohn M Lachin, Ionut Bebu, Xiaoyu Gao, et al.
Pageof 11